Lilly Company Profile

« Back to Dashboard

What is the competitive landscape for LILLY

LILLY has one hundred and five approved drugs.

Summary for Lilly

US Patents:	0
Tradenames:	85
Ingredients:	81
NDAs:	105

Drugs and US Patents for Lilly

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Lilly	TAZIDIME IN PLASTIC CONTAINER	ceftazidime	INJECTABLE;INJECTION	062739-001	Jul 10, 1986		DISCN	No	No
Lilly	HISTAMINE PHOSPHATE	histamine phosphate	INJECTABLE;INJECTION	000734-003	Approved Prior to Jan 1, 1982		DISCN	No	No
Lilly	HISTALOG	betazole hydrochloride	INJECTABLE;INJECTION	009344-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Lilly	KEFLET	cephalexin	TABLET;ORAL	050440-002	Approved Prior to Jan 1, 1982		DISCN	No	No
Lilly	TAZIDIME	ceftazidime	INJECTABLE;INJECTION	062655-002	Nov 20, 1985		DISCN	No	No
Lilly	TAZIDIME	ceftazidime	INJECTABLE;INJECTION	062655-001	Nov 20, 1985		DISCN	No	No
Lilly	DECABID	indecainide hydrochloride	TABLET, EXTENDED RELEASE;ORAL	019693-001	Dec 29, 1989		DISCN	No	No

Expired US Patents for Lilly

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Lilly	SYMBYAX	fluoxetine hydrochloride; olanzapine	CAPSULE;ORAL	021520-002	Dec 24, 2003	522,982
Lilly	EVISTA	raloxifene hydrochloride	TABLET;ORAL	020815-001	Dec 9, 1997	8,030,330
Lilly	EVISTA	raloxifene hydrochloride	TABLET;ORAL	020815-001	Dec 9, 1997	5,659,087
Lilly	FORTEO	teriparatide	SOLUTION;SUBCUTANEOUS	021318-001	Nov 26, 2002	7,351,414
Lilly	FORTEO	teriparatide	SOLUTION;SUBCUTANEOUS	021318-002	Jun 25, 2008	7,351,414
Lilly	FORTEO	teriparatide	SOLUTION;SUBCUTANEOUS	021318-002	Jun 25, 2008	7,550,434
Lilly	DECABID	indecainide hydrochloride	TABLET, EXTENDED RELEASE;ORAL	019693-002	Dec 29, 1989	4,389,393

Paragraph IV (Patent) Challenges for LILLY drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
	Delayed-release Capsules	40 mg		2012-05-10
	Capsules	6 mg/25 mg, 12 mg/25 mg, 6 mg/50 mg and 12 mg/50 mg		2005-01-10
	For Injection	200 mg/vial		2005-11-01
	For Injection	2 g/vial		2007-08-24
	For Injection	500 mg/vial		2008-02-04
	For Injection	750 mg/vial		2016-10-06
	Tablets	2.5 mg		2008-10-14
	Delayed-release Capsules	20 mg, 30 mg and 60 mg		2008-08-04
	Capsules	10 mg, 18 mg, 25 mg, 40 mg, 60 mg, 80 mg and 100 mg		2007-05-29
	Capsules	3 mg/25 mg		2008-05-08
	For Injection	1g/vial		2005-11-14
	For Injection	100 mg/vial		2008-07-01
	For Injection	1000 mg/vial		2012-06-27
	Injection	250 mcg/mL, 2.4 mL prefilled Pen		2015-07-27
	Tablets	5 mg, 10 mg and 20 mg		2007-11-21

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Lilly
• Lilly Res Labs